1.
Przegl Dermatol
; 76(1): 54-7, 1989.
Artigo
em Polonês
| MEDLINE
| ID: mdl-2813819
RESUMO
In 55-year-old woman with a history of 19 years of superficial disseminated actinic porokeratosis Tigason was used in doses from 0.7 to 0.5 mg/kg daily in two courses of therapy lasting about 3 months. The clinical improvement lasted for several months and their followed by less pronounced but progressive reappearance of clinical symptoms.
Assuntos
Etretinato/uso terapêutico , Ceratose/tratamento farmacológico , Paraceratose/tratamento farmacológico , Feminino , Humanos , Pessoa de Meia-Idade
2.
Przegl Dermatol
; 70(1): 61-4, 1983.
Artigo
em Polonês
| MEDLINE
| ID: mdl-6228962
3.
Przegl Dermatol
; 69(1-2): 75-8, 1982.
Artigo
em Polonês
| MEDLINE
| ID: mdl-7178494
4.
Przegl Dermatol
; 68(1): 67-70, 1981.
Artigo
em Polonês
| MEDLINE
| ID: mdl-6454174